Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Amino-PEG12-Boc | 1383814-00-3 | 98.0% | C31H63NO14 | 25 MG
SDP

Catalog No. 5000352653
Encompass_Preferred

Amino-PEG12-Boc is a PEG-based PROTAC linker for synthesizing PROTACs. PROTACs (Proteolysis Targeting Chimeras) are designed with two ligands connected by a linker, one targeting an E3 ubiquitin ligase and the other a target protein, to exploit the ubiquitin-proteasome system for selective degradation of proteins.

  • PEG-based PROTAC linker
  • Utilized in the synthesis of PROTACs
  • PROTACs contain two ligands connected by a linker
  • One ligand targets an E3 ubiquitin ligase
  • The other ligand targets a specific protein
  • Exploits the intracellular ubiquitin-proteasome system
  • Enables selective degradation of target proteins

Catalog No. 50-003-52653 Supplier Medchemexpress LLC Supplier No. 25MGHY140197
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Amino-PEG12-Boc is a PEG-based PROTAC linker for synthesizing PROTACs. PROTACs (Proteolysis Targeting Chimeras) are designed with two ligands connected by a linker, one targeting an E3 ubiquitin ligase and the other a target protein, to exploit the ubiquitin-proteasome system for selective degradation of proteins.

  • PEG-based PROTAC linker
  • Utilized in the synthesis of PROTACs
  • PROTACs contain two ligands connected by a linker
  • One ligand targets an E3 ubiquitin ligase
  • The other ligand targets a specific protein
  • Exploits the intracellular ubiquitin-proteasome system
  • Enables selective degradation of target proteins

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.